Literature DB >> 23887183

Hepatitis B virus genotype D predominates HBsAg-positive egyptian blood donors and is mainly associated with a negative HBeAg serostatus.

Fe E Habil1, W K M Mahdi, S F Abdelwahab, M Abdel-Hamid.   

Abstract

OBJECTIVES: Hepatitis B virus (HBV) infection is a global health burden. In this regard, Egypt has an intermediate HBV seroprevalence. HBV is classified into ten different genotypes (A-J) with different geographic distributions. Genotype D is the most prevalent in the Middle East. Limited data are available about HBV genotyping among Egyptian blood donors, particularly in Upper Egypt. We examined the seroprevalence of HBV among 12,000 blood donors attending the blood transfusion services center in Minia Governorate, Upper Egypt.
METHODS: HBsAg and HBeAg were examined by ELISA while HBV-DNA was examined by PCR. HBV genotyping was conducted by restriction fragment length polymorphism.
RESULTS: HBsAg was detected in 237 donors (1.98%). The HBV-DNA of 50 donors with the highest HBsAg OD was examined for the HBV genotype. All 50 DNA-positive samples were of genotype D. 82% of the DNA-positive donors were males, coinciding with their representation in the cohort. ALT levels were normal in 88% of genotyped subjects, while 84% of them were HBeAg negative.
CONCLUSION: Taken together, these data indicate that HBV genotype D is the predominant genotype among HBsAg-positive blood donors in Upper Egypt and was in >80% of the subjects associated with a negative HBeAg serostatus.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23887183     DOI: 10.1159/000353105

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  5 in total

1.  Association between interferon-gamma (IFN-γ) gene polymorphisms (+874A/T and +2109A/G), and susceptibility to hepatitis B viral infection (HBV).

Authors:  Mahmoud F Dondeti; Mohamed S Abdelkhalek; Hosam M El-Din Elezawy; Walaa F Alsanie; Bassem M Raafat; Amira M Gamal-Eldeen; Roba M Talaat
Journal:  J Appl Biomed       Date:  2022-01-12       Impact factor: 1.797

2.  Genotyping and sero-virological characterization of hepatitis B virus (HBV) in blood donors, Southern Ethiopia.

Authors:  Henock Ambachew; Meijuan Zheng; Faustina Pappoe; Jilong Shen; Yuanhong Xu
Journal:  PLoS One       Date:  2018-02-20       Impact factor: 3.240

3.  Analysis of clinical and virologic features in Hepatitis B e Antigen (HbeAg)-negative and HbeAg-positive Egyptian chronic hepatitis B patients.

Authors:  Rabab Fouad; Sherief Musa; Dina Sabry; Ahmad Salama; Shereen Abdel Alem; Mira Atef; Naglaa Zayed
Journal:  Afr Health Sci       Date:  2020-06       Impact factor: 0.927

Review 4.  The HBsAg Prevalence Among Blood Donors From Eastern Mediterranean and Middle Eastern Countries: A Systematic Review and Meta-Analysis.

Authors:  Mehran Babanejad; Neda Izadi; Farid Najafi; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2016-03-26       Impact factor: 0.660

5.  Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis.

Authors:  Mingjuan Tan; Ajeet S Bhadoria; Fuqiang Cui; Alex Tan; Judith Van Holten; Philippa Easterbrook; Nathan Ford; Qin Han; Ying Lu; Marc Bulterys; Yvan Hutin
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-11-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.